Compare ATRC & IIPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ATRC | IIPR |
|---|---|---|
| Founded | 2000 | 2016 |
| Country | United States | United States |
| Employees | N/A | 23 |
| Industry | Medical/Dental Instruments | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.6B |
| IPO Year | 2005 | N/A |
| Metric | ATRC | IIPR |
|---|---|---|
| Price | $28.17 | $57.37 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 3 |
| Target Price | ★ $51.17 | $45.00 |
| AVG Volume (30 Days) | ★ 769.9K | 300.7K |
| Earning Date | 05-05-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 14.28% |
| EPS Growth | ★ 74.74 | N/A |
| EPS | N/A | N/A |
| Revenue | ★ $201,630,000.00 | N/A |
| Revenue This Year | $15.27 | $2.69 |
| Revenue Next Year | $12.21 | $3.80 |
| P/E Ratio | ★ N/A | $10.92 |
| Revenue Growth | ★ 15.40 | N/A |
| 52 Week Low | $25.52 | $44.58 |
| 52 Week High | $43.18 | $61.40 |
| Indicator | ATRC | IIPR |
|---|---|---|
| Relative Strength Index (RSI) | 49.86 | 57.80 |
| Support Level | $26.47 | $52.70 |
| Resistance Level | $30.75 | $58.02 |
| Average True Range (ATR) | 1.36 | 2.02 |
| MACD | 0.20 | -0.06 |
| Stochastic Oscillator | 69.14 | 45.44 |
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
Innovative Industrial Properties Inc is a real estate investment trust focused on the acquisition, ownership and management of specialized industrial and commercial properties in the United States. Its properties are prominently leased to state-licensed operators for their regulated cannabis facilities. The company conducts its business through a traditional umbrella partnership real estate investment trust, or UPREIT structure, in which properties are owned by its Operating Partnership, directly or through subsidiaries. Its segments are: Cannabis Portfolio and Life Science Portfolio, with the majority of revenue coming from the Cannabis Portfolio segment, which involves acquiring, developing, and leasing real estate to regulated cannabis operators on long-term triple-net leases.